Clinical trial
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation With or…
NCT00005589 · EBMT Solid Tumors Working Party, Other · Completed
Key facts
| NCT number | NCT00005589 |
|---|---|
| Title | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma |
| Official title | Randomized Study of Rituximab (Mabthera) in Patients With Relapsed Follicular Lymphoma Prior to High-Dose Therapy as In Vivo Purging and to Maintain Remission Following High-Dose Therapy |
| Lead sponsor | EBMT Solid Tumors Working Party, Other |
| Collaborators | Lymphoma Trials Office |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Biological, Drug, Procedure |
| Interventions | filgrastim, rituximab, carmustine, cyclophosphamide, cytarabine, etoposide, melphalan, bone marrow ablation with stem cell support, peripheral blood stem cell transplantation |
| Enrollment | 460 |
| Start date | Oct 1, 1999 |
| Completion | Apr 1, 2013 |
| First posted | Jan 27, 2003 |
| Last update posted | Sep 17, 2013 |
| Countries | Australia, Austria, Belgium, Canada, Czechia, Denmark, France, Germany, Israel, New Zealand, Poland, Portugal and 5 more |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: